BDBM142046 US8927577, 27

SMILES: CC(C)CC(Nc1cnc2ccc(C)cc2c1)c1ccc(cc1)C(=O)NCCC(O)=O

InChI Key: InChIKey=QRKSJRJLTHRHMS-UHFFFAOYSA-N

Data: 1 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 142046   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Pro-glucagon (Homo sapiens (Human))	BDBM142046 (US8927577, 27) Show SMILES CC(C)CC(Nc1cnc2ccc(C)cc2c1)c1ccc(cc1)C(=O)NCCC(O)=O Show InChI InChI=1S/C25H29N3O3/c1-16(2)12-23(28-21-14-20-13-17(3)4-9-22(20)27-15-21)18-5-7-19(8-6-18)25(31)26-11-10-24(29)30/h4-9,13-16,23,28H,10-12H2,1-3H3,(H,26,31)(H,29,30)	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	160	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Pfizer Inc. US Patent					Assay Description The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...				US Patent US8927577 (2015) BindingDB Entry DOI: 10.7270/Q29S1PRV
					More data for this Ligand-Target Pair